2 completed, 1 terminated, 1 unknown. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Leukocyte Adhesion Deficiency Syndrome: new trials by email Literature Review of Leukocyte Adhesion Deficiency Syndrome trials Research Report on Leukocyte Adhesion Deficiency Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gene Therapy for Patients With Leukocyte Adherence Deficiency (Follow-Up of Phase 1 Trial) Leukocyte Adhesion Deficiency Syndrome | Completed | National Cancer Institute (NCI) | 2 | 2001-08-15 | 2017-07-02 | |
| Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies anti-thymocyte globulin, busulfan, cyclophosphamide - Immunologic Deficiency Syndromes, Chediak-Higashi Syndrome | Not applicable | Terminated | Fairview University Medical Center | 2000-03-01 | 2009-10-15 | |
| Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I Interferon gamma - Leukocyte Adhesion Deficiency Syndrome | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 5 | 1999-04-01 | 2008-03-04 |
| Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders X-Linked Agammaglobulinemia, X-Linked Hyper IgM Syndrome | Unknown | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1995-07-01 | 2005-06-24 |
Leukocyte-Adhesion Deficiency Syndrome (4) · Bruton type agammaglobulinemia (2) · Communicable Diseases (2) · Genetic Diseases, Inborn (2) · Hyper-IgM Immunodeficiency Syndrome, Type 1 (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Leukocyte adhesion deficiency type 1 (2) · Primary Immunodeficiency Diseases (2) · Rare Diseases (2) · Wiskott-Aldrich Syndrome (2) · Chediak-Higashi Syndrome (1) · Common Variable Immunodeficiency (1) · Graft vs Host Disease (1) · Granulomatous Disease, Chronic (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Blood Coagulation Disorders (2) · Blood Coagulation Disorders, Inherited (2) · Blood Protein Disorders (2) · Cytopenia (2) · Disease Attributes (2) · Dysgammaglobulinemia (2) · Genetic Diseases, Inborn (2) · Genetic Diseases, X-Linked (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Hyper-IgM Immunodeficiency Syndrome (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Infections (2)
Antilymphocyte Serum (1) · Busulfan (1) · Cyclophosphamide (1) · Cyclosporine (1) · Etoposide (1) · Interferon-gamma (1) · Methotrexate (1) · Methylprednisolone (1) · Prednisone (1)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Fairview University Medical Center (1) · National Cancer Institute (NCI) (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (4)
Hans D. Ochs (1) · K. Scott Baker (1)